Genetic Tech Spn ADR (GENE)

$0.77 -0.02 (-1.92%)
Market Cap 3.37M
Revenue (ttm) 5.03M
Net Income (ttm) -7.88M
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin N/A
Debt to Equity Ratio N/A
Volume 22,600
Avg Vol 21,120
Day's Range N/A - N/A
Shares Out 4.41M
Stochastic %K 50%
Beta 1.12
Analysts Strong Buy
Price Target $2.50

Company Profile

Genetic Technologies Limited, a molecular diagnostics company, engages in the provision of predictive genetic testing and risk assessment tools to help physicians manage people's health in the America, Canada, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company operates through EasyDNA, AffinityDNA, and GeneType/Corporate segments. It offers BREVAGenplus, a clinically validated risk assessment test for non-hereditary breast cancer. The company also markets BREVAGenp...

Industry: Diagnostics & Research
Sector: Healthcare
Phone: 61 3 8412 7000
Fax: 61 3 8412 7040
Address:
321 Chapel Street, Level 1 Suite 7, Prahran, Australia
StocktwitsNews
StocktwitsNews May. 29 at 3:15 PM
The New York Times and Amazon Strike AI Content Deal: Retail’s Yet To React $NYT $AMZN $GENE $RSPC https://stocktwits.com/news/equity/markets/new-york-times-and-amazon-strike-ai-content-deal/ch0AswDRbtM
0 · Reply
IffiTrades
IffiTrades Apr. 30 at 4:02 PM
$GENE i remember making $16K on this stock in one day - RIP
0 · Reply
Brence04
Brence04 Mar. 21 at 5:18 PM
$GENE class action lawsuit here
1 · Reply
JAMESX5
JAMESX5 Mar. 20 at 2:35 PM
$GENE RIP
0 · Reply
CurtTyp3
CurtTyp3 Mar. 17 at 10:34 AM
$GENE
0 · Reply
Vrod10
Vrod10 Mar. 5 at 9:22 PM
$GENE is there any news on this one since delisting?
1 · Reply
kancunbum
kancunbum Feb. 14 at 12:24 AM
$GENE a positive article today! Wahoooo https://www.prnewswire.com/news-releases/biomerieux-launches-gene-up-typer-an-innovative-diagnostic-solution-for-food-industries-to-rapidly-analyze-the-root-cause-of-contamination-of-listeria-monocytogenes-302375381.html
0 · Reply
lax346
lax346 Feb. 10 at 9:21 PM
$GENE what happens with it? Is it closed or banrupt?
0 · Reply
ChrisYanaki
ChrisYanaki Feb. 8 at 7:53 PM
$GENE https://www.listcorp.com/asx/gtg/genetic-technologies-limited/news/notice-of-reconvened-second-meeting-of-creditors-3147888.html At the Reconvened Meetings, creditors will be asked to decide and vote on whether:■the Company should execute a DOCA (if applicable); or■the administration of the Company should end; or■the Company should be wound up.As the Company is insolvent with no funds to pay its debts and no proposal for a DOCA has been received, the Administrators consider it is in creditors’ interests for the Company to be wound up.
0 · Reply
kancunbum
kancunbum Feb. 2 at 5:19 PM
$GENE this is good right?
0 · Reply
Latest News on GENE
BioVie and Genetic Technologies Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

Oct 11, 2024, 9:00 AM EDT - 9 months ago

BioVie and Genetic Technologies Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

BIVI

Join Genetic Technology's Exclusive Live Investor Webinar and Q&A Session on October 2

Sep 23, 2024, 8:30 AM EDT - 9 months ago

Join Genetic Technology's Exclusive Live Investor Webinar and Q&A Session on October 2

Genetic Technologies Invited to Join Prestigious “CancerIQ” Online Platform - Provides Access to 45 Healthcare Systems and 250 Clinics

Sep 11, 2024, 8:15 AM EDT - 10 months ago

Genetic Technologies Invited to Join Prestigious “CancerIQ” Online Platform - Provides Access to 45 Healthcare Systems and 250 Clinics

Genetic Technologies Strategic Restructure Driving USA Sales Growth

Jul 26, 2024, 8:00 AM EDT - 11 months ago

Genetic Technologies Strategic Restructure Driving USA Sales Growth

Genetic Technologies Announces Appointment of Chief Financial Officer & Company Secretary

Jul 16, 2024, 8:00 AM EDT - 1 year ago

Genetic Technologies Announces Appointment of Chief Financial Officer & Company Secretary

GeneType Identifies 79.5% of People Tested are at Risk of Serious Disease

Jun 25, 2024, 8:00 AM EDT - 1 year ago

GeneType Identifies 79.5% of People Tested are at Risk of Serious Disease

Join Genetic Technologies' Exclusive Live Investor Webinar and Q&A Session on June 27

Jun 21, 2024, 8:00 AM EDT - 1 year ago

Join Genetic Technologies' Exclusive Live Investor Webinar and Q&A Session on June 27

Appendix 4C & Quarterly Business Update – March 2024

Apr 30, 2024, 8:00 AM EDT - 1 year ago

Appendix 4C & Quarterly Business Update – March 2024

Genetic Technologies Announces Closing of US$2 Million Registered Direct Offering

Apr 22, 2024, 3:00 PM EDT - 1 year ago

Genetic Technologies Announces Closing of US$2 Million Registered Direct Offering

Genetic Technologies Announces $2 Million Registered Direct Offering

Apr 18, 2024, 12:17 PM EDT - 1 year ago

Genetic Technologies Announces $2 Million Registered Direct Offering

Genetic Technologies and BioVie Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

Apr 12, 2024, 9:00 AM EDT - 1 year ago

Genetic Technologies and BioVie Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

BIVI

Genetic Technologies' Digital Strategy Ignites Significant Traction in US Market

Apr 2, 2024, 8:05 AM EDT - 1 year ago

Genetic Technologies' Digital Strategy Ignites Significant Traction in US Market

GTG to launch U.S. Customer Digital Media Sales Campaign

Feb 28, 2024, 8:00 AM EST - 1 year ago

GTG to launch U.S. Customer Digital Media Sales Campaign

Genetic Technologies Regains Compliance with Nasdaq Minimum Bid Price Requirement

Jan 5, 2024, 8:00 AM EST - 1 year ago

Genetic Technologies Regains Compliance with Nasdaq Minimum Bid Price Requirement

Genetic Technologies and BioVie Interviews to Air on the RedChip Small Stocks Big Money(R) Show on Bloomberg TV

Dec 29, 2023, 9:00 AM EST - 1 year ago

Genetic Technologies and BioVie Interviews to Air on the RedChip Small Stocks Big Money(R) Show on Bloomberg TV

BIVI

Genetic Technologies Limited Announces Ordinary Share Consolidation and ADS Ratio Change

Dec 12, 2023, 8:00 AM EST - 1 year ago

Genetic Technologies Limited Announces Ordinary Share Consolidation and ADS Ratio Change

GeneType Predicting Risk of Pancreatic Cancer: Major Breakthrough in Early Detection and Treatment

Oct 18, 2023, 8:30 AM EDT - 1 year ago

GeneType Predicting Risk of Pancreatic Cancer: Major Breakthrough in Early Detection and Treatment

Knightscope, Soligenix, and Genetic Technologies Interviews to Air on the RedChip Small Stocks Big Money(R) Show on Bloomberg TV

Oct 6, 2023, 9:00 AM EDT - 1 year ago

Knightscope, Soligenix, and Genetic Technologies Interviews to Air on the RedChip Small Stocks Big Money(R) Show on Bloomberg TV

KSCP SNGX

GTG Signs Precision Medicine Pilot with Australia's Largest Private Hospital Network

Sep 27, 2023, 9:00 AM EDT - 1 year ago

GTG Signs Precision Medicine Pilot with Australia's Largest Private Hospital Network

Aridis Pharmaceuticals, Inc., Genetic Technologies Limited, and American Resources Corporation Interviews to Air on the RedChip Money Report(R) on Bloomberg TV

Sep 15, 2023, 9:00 AM EDT - 1 year ago

Aridis Pharmaceuticals, Inc., Genetic Technologies Limited, and American Resources Corporation Interviews to Air on the RedChip Money Report(R) on Bloomberg TV

AREC

GENE Positioned at the Forefront of Multi-cancer Clinical Utility Research - MRFF Grant names GTG as sole Industry Partner

Sep 11, 2023, 8:30 AM EDT - 1 year ago

GENE Positioned at the Forefront of Multi-cancer Clinical Utility Research - MRFF Grant names GTG as sole Industry Partner

Genetic Technologies Limited and 60 Degrees Pharmaceuticals Interviews to Air on the RedChip Money Report® on Bloomberg TV

Sep 1, 2023, 10:00 AM EDT - 1 year ago

Genetic Technologies Limited and 60 Degrees Pharmaceuticals Interviews to Air on the RedChip Money Report® on Bloomberg TV

Genetic Technologies Limited and 60 Degrees Pharmaceuticals Interviews to Air on the RedChip Money Report(R) on Bloomberg TV

Sep 1, 2023, 9:00 AM EDT - 1 year ago

Genetic Technologies Limited and 60 Degrees Pharmaceuticals Interviews to Air on the RedChip Money Report(R) on Bloomberg TV

SXTP

Annual Results – Momentum Building on our Commercial Plans

Aug 30, 2023, 8:45 AM EDT - 1 year ago

Annual Results – Momentum Building on our Commercial Plans

Cardio Diagnostics Partners With FRSTeam of East Kansas and West Missouri to Host First Onsite Heart Disease Fair in Kansas Using Epigenetic-Genetic Technologies

Aug 18, 2023, 8:30 AM EDT - 2 years ago

Cardio Diagnostics Partners With FRSTeam of East Kansas and West Missouri to Host First Onsite Heart Disease Fair in Kansas Using Epigenetic-Genetic Technologies

CDIO

Genetic Technologies Limited (GENE) Q4 2023 Earnings Call Transcript

Aug 9, 2023, 12:11 AM EDT - 2 years ago

Genetic Technologies Limited (GENE) Q4 2023 Earnings Call Transcript

Genetic Technologies Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency

Jul 21, 2023, 8:00 AM EDT - 2 years ago

Genetic Technologies Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency

Genetic Technologies Limited (GENE) Q3 2023 Earnings Call Transcript

May 3, 2023, 11:45 PM EDT - 2 years ago

Genetic Technologies Limited (GENE) Q3 2023 Earnings Call Transcript

New Publication Validates geneType for Melanoma Risk Assessment

Apr 28, 2023, 8:00 AM EDT - 2 years ago

New Publication Validates geneType for Melanoma Risk Assessment

Back-to-back Studies Validate geneType Breast Cancer Risk Test

Mar 13, 2023, 8:00 AM EDT - 2 years ago

Back-to-back Studies Validate geneType Breast Cancer Risk Test

Genetic Technologies Limited (GENE) Q2 2023 Earnings Call Transcript

Feb 27, 2023, 7:56 PM EST - 2 years ago

Genetic Technologies Limited (GENE) Q2 2023 Earnings Call Transcript

Genetic Technologies Announces Closing of $5 Million Registered Direct Offering

Feb 7, 2023, 10:00 AM EST - 2 years ago

Genetic Technologies Announces Closing of $5 Million Registered Direct Offering

Genetic Technologies to Launch Ground-breaking Comprehensive Risk Test for Breast & Ovarian Cancer

Feb 6, 2023, 8:00 AM EST - 2 years ago

Genetic Technologies to Launch Ground-breaking Comprehensive Risk Test for Breast & Ovarian Cancer

Genetic Technologies Announces $5 Million Registered Direct Offering

Feb 3, 2023, 8:35 AM EST - 2 years ago

Genetic Technologies Announces $5 Million Registered Direct Offering

GENE to Launch World's First Comprehensive Risk Test for Breast & Ovarian Cancer

Feb 3, 2023, 8:00 AM EST - 2 years ago

GENE to Launch World's First Comprehensive Risk Test for Breast & Ovarian Cancer

Quarterly Business Update – December 2022; Sixth Consecutive Quarter of Growth

Jan 30, 2023, 8:00 AM EST - 2 years ago

Quarterly Business Update – December 2022; Sixth Consecutive Quarter of Growth

GeneType published in PLOS ONE – development of polygenic risk scores for cardiovascular diseases and type 2 diabetes

Dec 6, 2022, 8:00 AM EST - 2 years ago

GeneType published in PLOS ONE – development of polygenic risk scores for cardiovascular diseases and type 2 diabetes

Genetic Technologies Limited (GENE) Q1 2023 Earnings Call Transcript

Nov 6, 2022, 6:59 AM EST - 2 years ago

Genetic Technologies Limited (GENE) Q1 2023 Earnings Call Transcript

Genetic Technologies Announces Q1 FY23 Quarterly Results and Investor Webinar Details

Oct 25, 2022, 9:14 AM EDT - 2 years ago

Genetic Technologies Announces Q1 FY23 Quarterly Results and Investor Webinar Details

Genetic Technologies Limited Interview to Air on Bloomberg U.S. on the RedChip Money Report(R)

Oct 13, 2022, 8:00 AM EDT - 2 years ago

Genetic Technologies Limited Interview to Air on Bloomberg U.S. on the RedChip Money Report(R)

Journal of Precision Medicine publication confirms GeneType Risk Test outperforms traditional risk assessments for breast cancer

Sep 29, 2022, 8:00 AM EDT - 2 years ago

Journal of Precision Medicine publication confirms GeneType Risk Test outperforms traditional risk assessments for breast cancer

Genetic Technologies Provides Update on US Operations and Payer Engagement

Sep 2, 2022, 8:00 AM EDT - 3 years ago

Genetic Technologies Provides Update on US Operations and Payer Engagement

GENE Momentum building - a year in review

Aug 30, 2022, 8:00 AM EDT - 3 years ago

GENE Momentum building - a year in review

Gene achieves key milestones and growth

Jul 28, 2022, 8:00 AM EDT - 3 years ago

Gene achieves key milestones and growth

Completion of AffinityDNA Acquisition expanding global direct-to-consumer business

Jul 14, 2022, 8:00 AM EDT - 3 years ago

Completion of AffinityDNA Acquisition expanding global direct-to-consumer business

GeneType Risk Assessment Test onboarding in 16 clinics

Jul 1, 2022, 8:00 AM EDT - 3 years ago

GeneType Risk Assessment Test onboarding in 16 clinics

Acquisition of global direct to consumer ecommerce business

May 16, 2022, 9:00 AM EDT - 3 years ago

Acquisition of global direct to consumer ecommerce business

Genetic Technologies Limited (GENE) CEO Simon Morriss on Q3 2022 Results - Earnings Call Transcript

Apr 20, 2022, 10:54 PM EDT - 3 years ago

Genetic Technologies Limited (GENE) CEO Simon Morriss on Q3 2022 Results - Earnings Call Transcript

Genetic Technologies drives leadership in precision medicine with Multi-Risk Test

Apr 8, 2022, 8:00 AM EDT - 3 years ago

Genetic Technologies drives leadership in precision medicine with Multi-Risk Test

Applied Genetic Technologies' (AGTC) CEO Sue Washer on Q2 2022 Results - Earnings Call Transcript

Feb 14, 2022, 1:01 PM EST - 3 years ago

Applied Genetic Technologies' (AGTC) CEO Sue Washer on Q2 2022 Results - Earnings Call Transcript

StocktwitsNews
StocktwitsNews May. 29 at 3:15 PM
The New York Times and Amazon Strike AI Content Deal: Retail’s Yet To React $NYT $AMZN $GENE $RSPC https://stocktwits.com/news/equity/markets/new-york-times-and-amazon-strike-ai-content-deal/ch0AswDRbtM
0 · Reply
IffiTrades
IffiTrades Apr. 30 at 4:02 PM
$GENE i remember making $16K on this stock in one day - RIP
0 · Reply
Brence04
Brence04 Mar. 21 at 5:18 PM
$GENE class action lawsuit here
1 · Reply
JAMESX5
JAMESX5 Mar. 20 at 2:35 PM
$GENE RIP
0 · Reply
CurtTyp3
CurtTyp3 Mar. 17 at 10:34 AM
$GENE
0 · Reply
Vrod10
Vrod10 Mar. 5 at 9:22 PM
$GENE is there any news on this one since delisting?
1 · Reply
kancunbum
kancunbum Feb. 14 at 12:24 AM
$GENE a positive article today! Wahoooo https://www.prnewswire.com/news-releases/biomerieux-launches-gene-up-typer-an-innovative-diagnostic-solution-for-food-industries-to-rapidly-analyze-the-root-cause-of-contamination-of-listeria-monocytogenes-302375381.html
0 · Reply
lax346
lax346 Feb. 10 at 9:21 PM
$GENE what happens with it? Is it closed or banrupt?
0 · Reply
ChrisYanaki
ChrisYanaki Feb. 8 at 7:53 PM
$GENE https://www.listcorp.com/asx/gtg/genetic-technologies-limited/news/notice-of-reconvened-second-meeting-of-creditors-3147888.html At the Reconvened Meetings, creditors will be asked to decide and vote on whether:■the Company should execute a DOCA (if applicable); or■the administration of the Company should end; or■the Company should be wound up.As the Company is insolvent with no funds to pay its debts and no proposal for a DOCA has been received, the Administrators consider it is in creditors’ interests for the Company to be wound up.
0 · Reply
kancunbum
kancunbum Feb. 2 at 5:19 PM
$GENE this is good right?
0 · Reply
kancunbum
kancunbum Feb. 2 at 5:18 PM
$GENE any news on this ticker?
1 · Reply
Brence04
Brence04 Jan. 29 at 10:16 PM
$GENE all the 20k watchers here did everyone sell or don’t care anymore ? No PR or updates at all
1 · Reply
MeiLingZhou
MeiLingZhou Jan. 22 at 4:13 PM
$GENE https://rhythmbio.com/ASX-Announcements~220
0 · Reply
TBoneP
TBoneP Jan. 16 at 3:55 PM
$GENE RIP
1 · Reply
Brence04
Brence04 Jan. 3 at 7:38 AM
$GENE any idea what’s next ? Is it now listed otc ?
2 · Reply
TickerStalker
TickerStalker Dec. 30 at 8:17 PM
$GENE Jeanie went back in the bottle. Never to be seen again. Erased from my brokerage.
2 · Reply
Piggly_Wiggly21
Piggly_Wiggly21 Dec. 24 at 5:55 PM
$GENE Melbourne-based bowel cancer diagnostics developer Rhythm Biosciences (ASX: RHY) has acquired the GeneType disease prediction business for $625,000 from Genetic Technologies (ASX: GTG), which entered administration last month after falling short in an attempted $2 million capital raise ouch…..!! https://www.businessnewsaustralia.com/articles/rhythm-biosciences-picks-up-disease-prediction-business-genetype-from-administration.html#:~:text=Melbourne%2Dbased%20bowel%20cancer%20diagnostics,attempted%20%242%20million%20capital%20raise.
2 · Reply
MeiLingZhou
MeiLingZhou Dec. 23 at 1:35 PM
$GENE https://www.tipranks.com/news/company-announcements/rhythm-biosciences-expands-with-genetype-acquisition
0 · Reply
Shadowplays
Shadowplays Dec. 23 at 8:06 AM
$GENE just read rhythm biosciencies bought them out in Australia for close to nothing. News is from 9 hours ago. Not sure how this plays out
1 · Reply
Crisco
Crisco Dec. 20 at 12:41 PM
$GENE so not even otc market? Damn
1 · Reply
Brence04
Brence04 Dec. 18 at 3:34 PM
$GENE finally delisted what a great loss
1 · Reply
rb1234
rb1234 Dec. 18 at 12:54 PM
$GENE does anyone have any updates?
2 · Reply